PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 17, 2026PLOS Global Public Health0 citationsOpen Access

Interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon: Implications for implementation in developing countries

View Full Paper
YBYagaï BoubaAKAude Christelle Ka’eCACynthia Ayafor

Key Points

  • The aim was to assess interest in long-acting injectable ART among adolescents with perinatally acquired HIV in Cameroon.
  • Cross-sectional study among ART-experienced adolescents aged 10-19 years in Cameroon.
  • Data collected via structured questionnaires and clinical measurements for viral load and CD4 counts.
  • Logistic regression analysis conducted to identify factors associated with interest in LAI-ART.
  • 92.3% expressed interest in LAI-ART, primarily due to reduced pill burden and better adherence.
  • Prior awareness of LAI-ART had a significant impact, with those unaware showing 81% lower interest (p=0.036).
  • High fear of injection correlated to a 78% lower odds of interest in LAI-ART (p=0.017).

Abstract

Long-acting injectable antiretroviral therapy (LAI-ART) has the potential to transform HIV treatment for adolescents with perinatal HIV infection (APHI). Given the existing knowledge gaps surrounding this recent strategy, we aimed to assess interest in LAI-ART among ART-experienced APHI in Cameroon. We conducted a cross-sectional study among ART-experienced APHI aged 10–19 years, across four paediatric HIV clinics in the Centre region of Cameroon. Data were collected from 4 to 30 November 2024 using structured questionnaires to assess sociodemographic characteristics, awareness of, and interest in LAI-ART. HIV-1 viral load (VL) and CD4 cell counts were measured during the same period. Logistic regression analysis was used to identify factors associated with interest in switching to LAI-ART. Of 248 participants (48.8% female; median IQR age 15 13–17), 40.0% lived with a guardian and 75.8% had partial/full HIV-disclosure; 3.2% reported stigma. Clinically, 77.5% were in multi-month ARV-dispensation (MDSD) and 28.2% had poor ART-adherence; fear of injection was none/moderate/high in 73.4%, 15.7% and 10.9%, respectively. Viral undetectability (VL < 50 copies/mL) and CD4 ≥ 500 cells/mm³ were 71.6% and 72.5%, respectively. Overall, 92.3% expressed interest in LAI-ART, motivated by reduced pill burden/fatigue (63.7%) and expected better adherence (74.2%); 30.2% reported prior LAI-ART awareness. In multivariable analysis, no prior awareness had 81% lower odds of interest (p = 0.036). Compared with no-fear, moderate-fear was associated with 46% lower odds (p = 0.393), while high-fear was associated with 78% lower odds (p = 0.017). Disparities in sex, education, residence, adherence, virological response, or treatment history did not influence interest in LAI-ART. Among all respondents, 77.1% said they would choose LAI-ART if available, whereas 20.2% preferred MDSD. In this Cameroonian APHI cohort, awareness of LAI-ART was low despite high-interest once adolescents were informed. Rollout in low/middle-income countries should prioritise targeted education, youth-friendly counselling to close knowledge gaps, reduce fear and ensure equitable uptake.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bouba et al. (2026) studied this question.

synapsesocial.com/papers/6a095c5d7880e6d24efe2706https://doi.org/10.1371/journal.pgph.0006293
Ask AI
Helpful
Bookmark
Share
View Full Paper